Cancer Network | Colorectal Cancer
111 FOLLOWERS
Updates for oncologists treating colon and rectal cancer, including guidelines, therapies, and screening by colonoscopy, FIT, stool DNA, and fecal occult blood tests.
Cancer Network | Colorectal Cancer
3d ago
CheckMate-8HW assessed the efficacy of first-line nivolumab plus ipilimumab in patients with MSI-H/dMMR metastatic colorectal cancer ..read more
Cancer Network | Colorectal Cancer
3d ago
Data from the phase 3 CRC-PREVENT trial support the sensitivity of ColoSense in the detection of colorectal cancer ..read more
Cancer Network | Colorectal Cancer
2w ago
Patients who are African American appeared to have worse clinical stages of colon and rectal cancer during surgery in 2020 ..read more
Cancer Network | Colorectal Cancer
2w ago
ME-344 and bevacizumab can now have an additional 20 patients enrolled on the phase 1b trial for relapsed metastatic colorectal cancer ..read more
Cancer Network | Colorectal Cancer
3w ago
The PREEMPT trial analyzed samples from 27,010 average-risk adults to determine the specificity of detecting colorectal cancer ..read more
Cancer Network | Colorectal Cancer
3w ago
Data from the phase 1/2 KRYSTAL-1 trial may support adagrasib plus cetuximab as a new standard in previously treated metastatic KRAS G12C–mutated CRC ..read more
Cancer Network | Colorectal Cancer
1M ago
Long-term circulating tumor DNA responses appear to align with progression-free survival trends in a phase 2/3 trial of the GRANITE vaccine in those with microsatellite-stable colorectal cancer ..read more
Cancer Network | Colorectal Cancer
1M ago
Gut microbiome signatures may lead the way for more accurate treatments and diagnoses for patients with colorectal cancer ..read more
Cancer Network | Colorectal Cancer
1M ago
If possible, targeting the BER pathway for drug sensitivities may increase therapeutic options for managing solid cancers, wrote Channing Paller, MD ..read more
Cancer Network | Colorectal Cancer
2M ago
Results from part 3 of the phase 2a CORIST trial found that combining SCO-101 with chemotherapy improved the progression-free survival and clinical benefit rate in patients with metastatic colorectal cancer ..read more